Benefits & research / 5 MIN READ

Shilajit Benefits and Research: What the Human Studies Actually Show

Explore shilajit benefits research on testosterone, exercise and bone density. See what human studies measured, who took part and where the evidence stops.

THE SHORT ANSWER

Human studies have reported changes in testosterone, strength after fatigue and bone density with particular shilajit preparations. Those are separate findings in different populations. They do not establish that every product improves energy, muscle or general wellbeing.

Read the outcome before accepting the headline.

In this guide6 sections

01

What the trials measured

The findings below concern specific preparations and groups of people. This table helps distinguish the measured outcome from the broader claim.

Research questionWhat was measuredWhat remains unanswered
TestosteroneBlood hormone levels in middle-aged men over 90 daysWhether the change improves mood, muscle gain or sexual function
Muscle strength after fatigueStrength retained after a tiring exercise protocol over eight weeksWhether one serving improves a workout immediately
Bone healthBone mineral density in postmenopausal women with osteopenia over 48 weeksWhether treatment prevents fractures or benefits younger adults with healthy bones

Testosterone in middle-aged men

A 90-day trial in healthy men aged 45–55 used purified shilajit twice daily and reported higher total and free testosterone than placebo. Participants and investigators did not know the treatment allocation during the relevant trial period.

The finding concerns blood measurements in that population. It does not establish muscle gain, greater confidence or improved sexual function in younger people. Those outcomes would need their own measurements.

The trial also did not compare morning with evening use. Its schedule does not establish a best time to take another product.

Strength after a tiring exercise protocol

An eight-week trial involved 63 recreationally active men. In the stronger half of participants at baseline, the higher-dose group showed less decline in strength after fatigue than placebo.

That is a narrower finding than “everyone became stronger.” It also does not show that one serving just before exercise works as a fast-acting pre-workout supplement.

A separate resin pilot followed 25 men for 28 days and reported improved leg-press performance. It had no comparison group. Training, familiarity with the test and other changes could therefore have contributed, and several authors worked for the product developer.

The safety article discusses the adverse events reported in that pilot.

Bone density in women with osteopenia

A 48-week trial involved 60 postmenopausal women with osteopenia. The extract groups lost less bone mineral density at the measured spine and hip sites than the placebo group.

The study did not establish fewer fractures. Nor does it tell a younger adult with healthy bones what benefit to expect.

If you have diagnosed low bone density, discuss treatment with your clinician rather than replacing it with a supplement.

02

A performance test does not answer every energy claim

Strength retained after fatigue and a person's report of everyday tiredness are different outcomes. The exercise findings above do not establish a treatment for persistent fatigue.

The same discipline applies to hormones. A blood-marker change cannot be expanded into mood, muscle or sexual-function benefits that the study did not measure.

A review saying “I feel better” adds another kind of information. It may describe an honest experience, but it cannot isolate the contribution of sleep, expectations, training or other changes.

03

Why the comparison group matters

People can improve through practice, expectations or changes in routine. A placebo comparison helps separate those influences from the additional change associated with the tested preparation.

Consider a fictional score:

GroupBeforeAfterChange
Supplement1012+2
Placebo1011+1

The additional change associated with the supplement is one point. Counting the full two-point improvement would ignore what happened in the comparison group.

Random allocation helps reduce systematic differences between groups. Blinding keeps participants, researchers or both unaware of allocation during relevant stages, limiting the influence of that knowledge.

Cell and animal research can investigate mechanisms. Human trials are more directly relevant to effects in people, but their design and population still determine what they can answer.

04

Read the size and uncertainty of the effect

“Statistically significant” does not tell you whether a difference matters in everyday life. Look at the size of the change and the range of values around the estimate, called a confidence interval. A wider range means the estimate is less precise.

After reading the abstract, look for the methods and numerical results. Record:

  • The preparation and amount tested.
  • Who enrolled, who completed and who entered the analysis.
  • The measured outcome and comparison group.
  • Dropouts and their reasons.
  • Adverse events and study duration.
  • Funding and declared conflicts of interest.

Commercial involvement does not automatically invalidate a result. It is relevant context, particularly where independent studies are scarce. Small, short studies also leave uncommon and long-term effects unresolved.

05

Match the study to the product

These trials used particular preparations, amounts and populations. The word “shilajit” does not make another resin, capsule or gummy equivalent.

None of the trials described here tested My Shilajit products. Their findings cannot be presented as results for those products.

Duration needs similar care. Measuring a change at 90 days does not identify when it began or whether someone would notice it. Study length is not a personal countdown to feeling a benefit.

06

Know what each source can establish

Scientific studies address effects in their tested participants and preparations. Official guidance addresses questions such as labelling and safety. Manufacturer instructions explain how to use that manufacturer's product.

Permission to mix resin into a warm drink is not evidence of a health effect.

When checking references, distinguish an abstract-only account from one based on the full paper. Also separate the study's publication date, the date someone accessed the reference and the article's substantive update date. They describe different events.

Worked figures in these guides are labelled illustrative when they are not real offers or measurements. They are not current brand rankings. Research findings and permitted advertising claims also remain separate questions.

Commercial context

My Shilajit publishes these guides and sells or develops the products displayed on its website. Product pages show availability. Those commercial links do not turn research on another preparation into evidence for a My Shilajit formulation.

THE REFERENCES

Go to the source.

  1. CONSORT 2025 expanded checklist for reporting randomised trialsAccessed 2026-10-04
  2. Cochrane Handbook: Interpreting results and drawing conclusionsAccessed 2026-10-04
  3. ASA: Food — Health claimsAccessed 2026-10-04
  4. Pandit et al.: Clinical evaluation of purified Shilajit on testosterone levels in healthy volunteers (abstract)Accessed 2026-10-04
  5. Yadav et al.: 28-day open-label pilot of TruBlk shilajit resin (abstract)Accessed 2026-10-04
  6. Pingali and Nutalapati: Shilajit extract and bone mineral density in postmenopausal women with osteopenia (abstract)Accessed 2026-10-04
  7. Keller et al. (2019): strength after a fatiguing protocol — abstractAccessed 2026-10-04